Inventor · disambiguated record
Rakesh Datta
Also filed as: DATTA RAKESH
4 granted patents·7 pending applications·22 citations·filing 2006–2020
75Inventor score
Top patents by PatentIndex Score
11 records- 0188US7932231B2Compositions and methods for stimulating gastrointestinal motilityIPSEN PHARMA SAS·Filed 2006·Granted Apr 26, 2011·10 cites·25 claims
- 0285US8871706B2Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogueDONG ZHENG XIN·Filed 2008·Granted Oct 28, 2014·6 cites·6 claims
- 0378US8981054B2Compositions and methods for stimulating gastrointestinal motilityDATTA RAKESH·Filed 2011·Granted Mar 17, 2015·5 cites·24 claims
- 0476US2020347110A1Composition and Methods for Stimulating Gastrointestinal MotilityIPSEN PHARMA SAS·Filed 2019·Application pending·0 cites
- 0572US9499599B2Composition and methods for stimulating gastrointestinal motilityIPSEN PHARMA SAS·Filed 2015·Granted Nov 22, 2016·1 cites·24 claims
- 0667US2020360483A1METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUEIPSEN PHARMA SAS·Filed 2020·Application pending·0 cites
- 0764US2019248861A1Composition and Methods for Stimulating Gastrointestinal MotilityIPSEN PHARMA SAS·Filed 2018·Application pending·0 cites
- 0863US2015111823A1METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUEIPSEN PHARMA SAS·Filed 2014·Application pending·0 cites
- 0959US2017304403A1METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUEIPSEN PHARMA SAS·Filed 2017·Application pending·0 cites
- 1058US2017037104A1Composition and Methods for Stimulating Gastrointestinal MotilityIPSEN PHARMA SAS·Filed 2016·Application pending·0 cites
- 1155US2016206700A1METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUEIPSEN PHARMA SAS·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →